(1 - 16 from 23
)
FDA Watch List: Nexavar
news.cision.com
[CisionWire (press release)] - This drug is used to treat advanced renal cell carcinoma, which is a type of cancer that starts in the kidneys and unresectable hepatocellular carcinoma, which is a type of liver cancer, according to the National Center for Biotechnology Information.
Google News: US FDA backs new indications for Votrient and Afinitor
[The Pharma Letter] - Votrient generated global sales of about £100 million ($161 million) last year and achieved an 18% total prescription share in the US advanced renal cell carcinoma market by end “Soft tissue sarcomas are a diverse group of tumors and the approval
Google News: FDA Expands Everolimus Label
[MedPage Today] - The drug also is approved to treat renal cell carcinoma that has been treated unsuccessfully with other medications, and progressive neuroendocrine tumors in the pancreas that cannot be removed by surgery or that have spread to other areas of the body.
FDA grants priority review to belzutifan for renal cell carcinoma subsetwww.healio.com › news › hematology-oncology › fda-grants-priority-revi...
www.healio.com
6 days ago · Objective response rate among patients with von Hippel-Lindau disease-associated renal cell carcinoma served as the primary endpoint. Results ...
sorted by relevance / date